Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 1/20 | 0.31 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26301483 | 0.91 | NR3C1 (0.31) | GABRA1GABRB2KDM4E | |
| SCHEMBL26781739 | 0.86 | GABRA1 (0.32) | GABRA1GABRB2 | |
| SCHEMBL26793365 | 0.85 | CYP1A2 (0.33) | — | |
| SCHEMBL26834390 | 0.82 | HTR2A (0.35) | GABRA1GABRB2 | |
| SCHEMBL26796937 | 0.81 | GABRA1 (0.32) | GABRA1GABRB2 | |
| SCHEMBL26782101 | 0.81 | — | — | |
| SCHEMBL26049656 | 0.81 | CYP1A2 (0.33) | KDM4E | |
| SCHEMBL26781570 | 0.80 | LMNA (0.37) | — | |
| SCHEMBL26836500 | 0.80 | HTR2A (0.39) | GABRA1GABRB2 | |
| SCHEMBL25518666 | 0.79 | NR3C1 (0.33) | GABRA1GABRB2KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11832456-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2023-11-28 | — | — | US | disclosed |
| EP-3981776-B1 | USE OF AN ANCILLARY LIGAND IN A PHOSPHORESCENT METAL COMPLEX COMPOUND | UNIVERSAL DISPLAY CORP (US) | 2023-11-15 | — | — | EP | disclosed |
| US-20230295204-A1 | METAL COMPLEX AND USE THEREOF | GUANGDONG AGLAIA OPTOELECTRONIC MATERIALS CO., LTD (CN) | 2023-09-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11832456-B2 | Organic electroluminescent materials and devices | CPNE4, CYBA, EPCAM | GABRA1 2194/4885GABRB2 3045/4885KDM4E 807/4885 |
| US-20230295204-A1 | METAL COMPLEX AND USE THEREOF | IK, CYBA, LAS1L | GABRA1 3669/4885GABRB2 4259/4885KDM4E 4522/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.